Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by enriquesuaveon Aug 22, 2024 10:42am
157 Views
Post# 36191725

RE:Not photodynamic therapy

RE:Not photodynamic therapy

This could potentially be beyond huge!  We see that the combination of Rutherin and Metformin results in the same ROS formation as Rutherin and X-rays alone.  Basically what that would allow is for treatment of main tumors with Combination Ruherin-Metformin and X-rays for even greater ROS formation and tumor cell kill, and at the same time, any distant or undetected metastasis would be targeted and hopefully killed by Metformin activated Rutherin.  Whole body treatment with minimal X-radiation.  


Eoganacht wrote: To state the obvious, if Metaformin can successfully activate Rutherrin to produce ROS and selectively kill cancer cells then Theralase has left the realm of photodynamic therapy and joined the mainstream medical treatment world of needle sticking and pill popping. 

This should make at least some of Theralase's ACT more appealing to big pharma. If, in some futute procedure, patients aren't completely cancer free after taking their Rutherrin/Metaformin then doctors can freshen up the effect with a light dose of X-rays which are a pretty mainstream cancer treatment already.

The fact that both drugs can cross the blood-brain barrier might effect the design of the upcoming gbm trial by adding Metaformin to the Rutherrin, X-ray mix.

 

<< Previous
Bullboard Posts
Next >>